143 related articles for article (PubMed ID: 11346881)
1. Comparative analysis of ras proto-oncogene mutations in selected mammalian tumors.
Watzinger F; Mayr B; Gamerith R; Vetter C; Lion T
Mol Carcinog; 2001 Apr; 30(4):190-8. PubMed ID: 11346881
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
[TBL] [Abstract][Full Text] [Related]
3. Absence of ras-gene hot-spot mutations in canine fibrosarcomas and melanomas.
Murua Escobar H; Günther K; Richter A; Soller JT; Winkler S; Nolte I; Bullerdiek J
Anticancer Res; 2004; 24(5A):3027-8. PubMed ID: 15517911
[TBL] [Abstract][Full Text] [Related]
4. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
5. [Ras gene analysis in mammary tumors of dogs by means of PCR-SSCP and direct genomic analysis].
Castagnaro M
Ann Ist Super Sanita; 1995; 31(3):337-41. PubMed ID: 8712577
[TBL] [Abstract][Full Text] [Related]
6. [Incidence of point mutations in Ki-ras codon 12 and 13 in squamous epithelial carcinomas of the head-neck region].
Rathcke IO; Gottschlich S; Görögh T; Lippert BM; Werner JA
Laryngorhinootologie; 1996 Aug; 75(8):465-70. PubMed ID: 8962608
[TBL] [Abstract][Full Text] [Related]
7. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Kitada H; Tsutsumi M; Tsujiuchi T; Takahama M; Fukuda T; Narita N; Konsihi Y
Mol Carcinog; 1996 Apr; 15(4):276-83. PubMed ID: 8634086
[TBL] [Abstract][Full Text] [Related]
8. Absence of Ki-ras mutations in exocrine pancreatic tumors from male rats chronically exposed to gabapentin.
Fowler ML; Sigler RE; de la Iglesia FA; Reddy JK; Lalwani ND
Mutat Res; 1995 Mar; 327(1-2):151-60. PubMed ID: 7870083
[TBL] [Abstract][Full Text] [Related]
9. P21 protein expression and ras-oncogene mutations in gastric carcinoma: correlation with clinical data.
Kasper HU; Schneider-Stock R; Mellin W; Roessner A
Int J Oncol; 1998 Jan; 12(1):69-74. PubMed ID: 9454888
[TBL] [Abstract][Full Text] [Related]
10. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
11. H-ras oncogene point mutations in arthritic synovium.
Roivainen A; Jalava J; Pirilä L; Yli-Jama T; Tiusanen H; Toivanen P
Arthritis Rheum; 1997 Sep; 40(9):1636-43. PubMed ID: 9324018
[TBL] [Abstract][Full Text] [Related]
12. Synchronous colon carcinomas: molecular-genetic evidence for multicentricity.
Koness RJ; King TC; Schechter S; McLean SF; Lodowsky C; Wanebo HJ
Ann Surg Oncol; 1996 Mar; 3(2):136-43. PubMed ID: 8646513
[TBL] [Abstract][Full Text] [Related]
13. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
[TBL] [Abstract][Full Text] [Related]
14. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
15. Low incidence of Ha-ras oncogene mutations in human epidermal tumors.
Lieu FM; Yamanishi K; Konishi K; Kishimoto S; Yasuno H
Cancer Lett; 1991 Sep; 59(3):231-5. PubMed ID: 1913619
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.
Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF
Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874
[TBL] [Abstract][Full Text] [Related]
17. Frequent activation of the Ki-ras oncogene at codon 12 in N-methyl-N-nitrosourea-induced rat prostate adenocarcinomas and neurogenic sarcomas.
Sukumar S; Armstrong B; Bruyntjes JP; Leav I; Bosland MC
Mol Carcinog; 1991; 4(5):362-8. PubMed ID: 1680340
[TBL] [Abstract][Full Text] [Related]
18. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the role of the ras protooncogene point mutation in human uveal melanomas.
Soparker CN; O'Brien JM; Albert DM
Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2203-9. PubMed ID: 8505202
[TBL] [Abstract][Full Text] [Related]
20. Ki-ras mutations in spontaneous and chemically induced renal tumors of the rat.
Ohgaki H; Kleihues P; Hard GC
Mol Carcinog; 1991; 4(6):455-9. PubMed ID: 1793484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]